Social Capital Suvretta Holdings Corp. III

01/18/2022 | Press release | Distributed by Public on 01/18/2022 06:31

Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K